AlphaFold predicted structure
MYMX · A0A1B0GTQ4

Mean pLDDT
72.0/ 100
Confident
84 residues
Confidence breakdown
- Very high(≥ 90)2%
- Confident(70–90)61%
- Low(50–70)36%
- Very low(< 50)1%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
myomixer, myoblast fusion factor
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Congenital myopathy
BIALLELIC, autosomal or pseudoautosomalCarey-Fineman-Ziter syndrome
Carey-Fineman-Ziter syndrome
lymphatic system disorder
ovarian neoplasm
Congenital myasthenic syndromes
Postsynaptic congenital myasthenic syndromes
Hereditary proximal myopathy with early respiratory failure
Bethlem myopathy
congenital myasthenic syndromes with glycosylation defect
Distal myopathy, Nonaka type
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Protein myomixer
Myoblast-specific protein that mediates myoblast fusion, an essential step for the formation of multi-nucleated muscle fibers (PubMed:28569745, PubMed:35642635). Involved in membrane fusion downstream of the lipid mixing step mediated by MYMK (By similarity). Acts by generating membrane stresses via its extracellular C-terminus, leading to drive fusion pore formation. Acts independently of MYMK (By similarity). Involved in skeletal muscle regeneration in response to injury by mediating the fusion of satellite cells, a population of muscle stem cells, with injured myofibers (By similarity)
MYMX · A0A1B0GTQ4

Mean pLDDT
72.0/ 100
Confident
84 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0